SUNNYVALE, Calif., April 11, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the newly built Radiotherapy and Medical Oncology Center of Sidi Abdellah, Algeria is now treating cancer patients with the first TomoTherapy ® Systems installed in Africa. The TomoTherapy System is recognized worldwide for providing highly precise treatments for a broad range of cancer cases, from routine to complex. The first treatment was successfully delivered in February 2017 to a patient with breast cancer.The TomoTherapy Systems are two out of three Accuray systems to be installed and operated at the Center, located not far from the Technoparc of Sidi Abdellah in the suburbs of Algiers. The Radiotherapy and Medical Oncology Center also purchased one CyberKnife ® M6 ™ System which is scheduled to be installed by the end of 2018. With the two systems - CyberKnife and TomoTherapy - in one location, the Center will have the flexibility to efficiently and effectively treat virtually all patients who may benefit from this highly precise form of radiation therapy. "We are honored that the Radiotherapy and Medical Oncology Center team has selected the Accuray systems to expand their cancer treatment options. Their decision reinforces growing global recognition of the importance of radiation therapy in treating cancer," said Lionel Hadjadjeba, MD, Corporate Senior Vice President and President of Worldwide Commercial Operations at Accuray. "The TomoTherapy and CyberKnife Systems provide an optimal combination of efficacy and safety while minimizing the impact of treatment on daily lives, and will enable the clinical team to confidently provide each cancer patient with a treatment program that addresses his or her individual needs."